Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has issued an update.
Wai Chun Bio-Technology Limited announced a delay in the dispatch of a circular related to a connected transaction involving the issuance of new convertible bonds under a specific mandate. The circular, which includes detailed information about the subscription, recommendations from the Independent Board Committee, and advice from the Independent Financial Adviser, was initially expected to be sent by July 7, 2025, but will now be dispatched by July 31, 2025. This delay indicates the need for additional time to finalize certain information, potentially impacting shareholder expectations and the company’s financial planning.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Limited is a company incorporated in the Cayman Islands, operating within the biotechnology industry. The company is involved in the issuance of convertible bonds and engages with shareholders through structured financial transactions.
Average Trading Volume: 214,330
Technical Sentiment Signal: Buy
Current Market Cap: HK$24.45M
See more insights into 0660 stock on TipRanks’ Stock Analysis page.